Initiator Pharma A/S (STO:INIT)

Sweden flag Sweden · Delayed Price · Currency is SEK
2.900
-0.090 (-3.01%)
Mar 9, 2026, 5:06 PM CET
-51.67%
Market Cap 204.67M
Revenue (ttm) n/a
Net Income (ttm) -19.83M
Shares Out 68.45M
EPS (ttm) -0.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 71,415
Average Volume 82,088
Open 2.990
Previous Close 2.990
Day's Range 2.770 - 2.990
52-Week Range 2.560 - 8.000
Beta 0.10
RSI 43.12
Earnings Date Feb 20, 2026

About Initiator Pharma

Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. Its product pipeline includes Pudafensine, a monoamine reuptake inhibitor, which completed phase IIb clinical trial primarily targeting the dopamine system for treatment resistant organic erectile dysfunction, as well as completed phase I to treat neuropathic pain; and IP2018, a monoamine reuptake inhibitor which completed Phase IIa for the treatment of psychogenic erectile dysfunction. The ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 1
Stock Exchange Nasdaq Stockholm
Ticker Symbol INIT
Full Company Profile

Financial Performance

Financial numbers in DKK Financial Statements

News

There is no news available yet.